Incidence of Richter’s Transformation in the Targeted Therapy Era - Dr. Paul Hampel ASH 2023

CAR-T Therapy for Richter Transformation - Dr. Adam Kittai ASH 2023Подробнее

A research update in Richter's transformation from ASH 2023Подробнее

Triple Combination Therapy for Richter’s Transformation - Dr. Tamar Tadmor ASH 2023Подробнее

Risk-factors for Richter’s transformationПодробнее

Richter's syndrome: UpdateПодробнее

Pirtobrutinib for Richter's Transformation - Dr. William Wierda ASH 2023Подробнее

Promising agents emerging for Richter’s transformationПодробнее

Novel treatment regimens under investigation for Richter's transformationПодробнее

ASH highlights: glofitamab in DLBCL & pirtobrutinib and epcoritamab in Richter's transformationПодробнее

Therapeutic options for Richter’s syndromeПодробнее

Richter's Transformation & CAR T Therapy in #CLL | Dr. Adam Kittai, MD | ASH 2023Подробнее

Pirtobrutinib for Richter’s Transformation - Dr. Nirav Shah ASH 2022Подробнее

Case 3: Therapeutic Approaches for Richter TransformationПодробнее

The management of Richter's transformation: current approaches and future outlooksПодробнее

Advances in our understanding of the factors contributing to Richter’s transformation in CLLПодробнее

Treatment of Richter’s transformation: recent insightsПодробнее

The combination of copanlisib and nivolumab in patient's with Richter's transformationПодробнее

Advice for community physicians managing Richter's transformation of CLLПодробнее